COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,210,386 | -8.9% | 699,645 | +25.8% | 0.01% | -10.0% |
Q1 2024 | $1,328,709 | -28.2% | 555,945 | 0.0% | 0.01% | -33.3% |
Q4 2023 | $1,851,297 | -25.7% | 555,945 | -16.6% | 0.02% | -31.8% |
Q3 2023 | $2,491,756 | +44.3% | 666,245 | +64.7% | 0.02% | +57.1% |
Q2 2023 | $1,726,980 | +150.8% | 404,445 | +301.7% | 0.01% | +366.7% |
Q1 2023 | $688,720 | +72.7% | 100,690 | +100.0% | 0.00% | 0.0% |
Q4 2022 | $398,732 | -17.6% | 50,345 | 0.0% | 0.00% | -40.0% |
Q3 2022 | $484,000 | +28.0% | 50,345 | -3.6% | 0.01% | +66.7% |
Q2 2022 | $378,000 | -51.2% | 52,200 | -13.0% | 0.00% | -50.0% |
Q1 2022 | $775,000 | -19.1% | 60,000 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $958,000 | -20.6% | 60,000 | -20.1% | 0.01% | -22.2% |
Q3 2021 | $1,207,000 | +15.1% | 75,106 | -0.9% | 0.01% | +12.5% |
Q2 2021 | $1,049,000 | -83.3% | 75,819 | -79.0% | 0.01% | -84.6% |
Q4 2020 | $6,263,000 | +10.4% | 360,344 | +16.5% | 0.05% | -7.1% |
Q3 2020 | $5,672,000 | +107.6% | 309,224 | +102.2% | 0.06% | +100.0% |
Q2 2020 | $2,732,000 | – | 152,935 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,100,000 | $1,903,000 | 1.75% |
AlphaCentric Advisors LLC | 1,000,000 | $1,730,000 | 1.27% |
Tejara Capital Ltd | 1,030,386 | $1,782,568 | 0.65% |
Rubric Capital Management LP | 10,400,000 | $17,992,000 | 0.47% |
Birchview Capital, LP | 270,000 | $467,100 | 0.43% |
TANG CAPITAL MANAGEMENT LLC | 1,050,000 | $1,816,500 | 0.18% |
Bridge City Capital, LLC | 316,009 | $546,696 | 0.18% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $5,252,413 | 0.16% |
Tyche Wealth Partners LLC | 215,902 | $373,510 | 0.09% |
Pennant Investors, LP | 168,100 | $290,813 | 0.08% |